Resumption of motor vehicle operation in vasovagal fainters.

This study surveyed current practice patterns with respect to the manner by which cardiac arrhythmia specialists advise patients with vasovagal syncope regarding resumption of motor vehicle operation. Among 66 physician-respondents from 9 countries, 98% indicated that they rely on tilt-table testing to establish a diagnosis, and, if an effective treatment is found based on serial tilt-table testing, they recommend a 6- to 7-week symptom-free waiting period before advising return to driving.

[1]  L. Mont,et al.  Limitations of head-up tilt test for evaluating the efficacy of therapeutic interventions in patients with vasovagal syncope: results of a controlled study of etilefrine versus placebo. , 1995, Journal of the American College of Cardiology.

[2]  McLean Aj.  Death at the wheel. , 1970 .

[3]  E Grattan,et al.  Medical factors and road accidents. , 1968, British medical journal.

[4]  Hossack Dw,et al.  Death at the wheel. A consideration of cardiovascular disease as a contributory factor to road accidents. , 1974 .

[5]  C. Morillo,et al.  A placebo-controlled trial of intravenous and oral disopyramide for prevention of neurally mediated syncope induced by heap-up tilt , 1993 .

[6]  C. Gornick,et al.  Usefulness of disopyramide for prevention of upright tilt-induced hypotension-bradycardia. , 1990, The American journal of cardiology.

[7]  M. Brignole,et al.  A controlled trial of acute and long-term medical therapy in tilt-induced neurally mediated syncope. , 1992, The American journal of cardiology.

[8]  Arshed A. Quyyumi,et al.  Sudden Cardiac Death without Warning , 1989 .

[9]  B L Wilkoff,et al.  Personal and public safety issues related to arrhythmias that may affect consciousness: implications for regulation and physician recommendations. A medical/scientific statement from the American Heart Association and the North American Society of Pacing and Electrophysiology. , 1996, Circulation.

[10]  B. Grubb,et al.  Usefulness of Fluoxetine Hydrochloride for Prevention of Resistant Upright Tilt Induced Syncope , 1993, Pacing and clinical electrophysiology : PACE.

[11]  A. Natale,et al.  Efficacy of Different Treatment Strategies for Neurocardiogenic Syncope , 1995, Pacing and clinical electrophysiology : PACE.

[12]  S. Strickberger,et al.  When should patients with lethal ventricular arrhythmia resume driving? An analysis of state regulations and physician practices. , 1991, Annals of internal medicine.

[13]  John H. McAnulty,et al.  Recurrent Cardiac Events in Survivors of Ventricular Fibrillation or Tachycardia: Implications for Driving Restrictions , 1994 .

[14]  H Calkins,et al.  Incidence of loss of consciousness during automatic implantable cardioverter-defibrillator shocks. , 1991, Annals of internal medicine.